MD Anderson Cancer Center Offers an Essential 6-Day Course: Mastering Hematology & Oncology for ABIM Success
MD Anderson Cancer Center shared an inviting post on X:
”A virtual live-streaming course will offer comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.”
To learn more and register, follow the link.
A 6-day virtual course by MD Anderson Cancer Center and Baylor College of Medicine offers a comprehensive review of current practices in managing blood disorders and malignancies, tailored to help participants prepare for the ABIM certification in Hematology and Medical Oncology.
The program covers key updates in pharmacology, molecular genetics, risk assessment, and radiation oncology.
By the end of the course, participants will be equipped to:
- Confidently prepare for hematology and medical oncology subspecialty and recertification exams.
- Apply up-to-date standards of care in treating cancer, blood disorders, and malignancies.
- Demonstrate comprehensive knowledge in hematology and medical oncology.
- Integrate recent advances into the management of hematologic and oncologic patients.
Don’t miss your chance, apply now!
Stay informed on the latest conferences, courses, and webinars—read Hemostasis Today for all the updates!
-
Jan 5, 2026, 05:59Ageing With a Bleeding Disorder: Learn More About Healthy Ageing With EHC
-
Jan 5, 2026, 05:58Pernicious Anemia: What Is It, and How to Distinguish It From True Autoimmune Hemolytic Anemia – Explained by Tareq Abadl
-
Jan 5, 2026, 05:55Somnath Mukherjee and Satya Prakash Explore Cord Blood Exosomes as a Future SCD Therapeutic
-
Jan 5, 2026, 05:54Nathan Connell on Real-World Evidence: A Safe Switch to New rFVIIa Avoided Over $550K in Costs
-
Jan 5, 2026, 05:53Heghine Khachatryan on ITP’s Key Research Gaps: Biomarkers, Fatigue and Thrombosis Risk
-
Jan 4, 2026, 23:57Syed Harris J on Massage Guns: Recovery Tool or ER Risk?
-
Jan 4, 2026, 21:39Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
-
Jan 4, 2026, 20:30Zeeshan Ahmed Khattak: Why Every Pharmacist Should Consider an Anticoagulation Certification
-
Jan 4, 2026, 17:02Oğuzhan Işılay on Stabilizing Human Blood Clotting Factor VIII